USE OF MEMBRANE PROTEINS ASSOCIATED WITH BREAST CANCER (BCPM) FOR THE TREATMENT, PROFILAXIS AND DIAGONOSIS OF BREAST CANCER.

摘要

The use of an antibody capable of immunospecific binding to BST-2 (BCMP-17) or one of its fragments or derivatives comprising the antibody binding domain, in the manufacture of a medicament for the treatment of breast cancer.